HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Small molecule selectin inhibitor in global cerebral ischemia and controlled hemorrhagic shock.

AbstractBACKGROUND:
The clinical and experimental management of stroke has not reached the therapeutic success seen in other medical conditions associated with ischemia/reperfusion. In this work, we investigated the effect of a small molecule selectin inhibitor TBC-1269, in animals subjected to global cerebral ischemia (GCI) and controlled hemorrhagic shock (CHS).
METHODS:
Forty-eight male Sprague-Dawley rats weighting between 275 g and 300 g were subjected to a model of GCI and CHS. Three groups of animals were included in this study (n = 16 per group): sham/saline (group 1); GCI/CHS/Saline (group 2); GCI/CHS/TBC-1269 (group 3). Experimental design consisted of bilateral carotid artery occlusion for 20 minutes, and the development of CHS until a mean arterial pressure of 50 mm Hg was reached. At 20 minutes, clamps were released, and resuscitation was achieved with normal saline, and the end point was to attain a mean arterial pressure of 80 mm Hg. Treatment at the beginning of resuscitation included either normal saline (groups 1 and 2) or TBC-1269 (25 mg/kg, group 3). The following indices were evaluated: brain tissue myeloperoxidase, average numbers of ischemic neurons, and 7-day survival.
RESULTS:
Brain myeloperoxidase was decreased in animals treated with TBC-1269, although this difference was not statistically significant. Treated animals demonstrated a significant smaller amount of ischemic neurons than the controls. Survival was also improved from 40% in controls to 80% with TBC-1269 treatment. This difference was statistically significant.
CONCLUSION:
The use of a small molecule selectin inhibitor, TBC-1269, had a protective effect in this model of GCI and CHS, as evidenced by decreased numbers of ischemic neurons and improved survival rates.
AuthorsRoberto Anaya-Prado, Nahum Pérez-Gomez, Luis H Toledo-Pereyra, John Walsh, Jackie Jordan, Peter A Ward
JournalThe Journal of trauma (J Trauma) Vol. 65 Issue 3 Pg. 678-84 (Sep 2008) ISSN: 1529-8809 [Electronic] United States
PMID18784584 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biphenyl Compounds
  • Cell Adhesion Molecules
  • Mannosides
  • bimosiamose disodium
  • Peroxidase
  • Mannose
Topics
  • Animals
  • Biphenyl Compounds (therapeutic use)
  • Brain Ischemia (drug therapy, enzymology, pathology)
  • Cell Adhesion Molecules (antagonists & inhibitors)
  • Disease Models, Animal
  • Male
  • Mannose (analogs & derivatives)
  • Mannosides (therapeutic use)
  • Neutrophil Infiltration
  • Peroxidase (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Shock, Hemorrhagic (drug therapy, enzymology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: